| References |
|
|
Berry HK
(1987)
Screening for mucopolysaccharide disorders with the Berry spot test.
Clinical Biochemistry
20:
365–371.
|
|
|
Bitter T and
Muir HM
(1962)
A modified uronic acid carbazole reaction.
Analytical Biochemistry
4:
330–334.
|
|
|
Brante G
(1952)
Gargoylism: a mucopolysaccharidosis.
Scandinavian Journal of Clinical and Laboratory Investigation
4:
43–46.
|
|
|
ePath
Clarke LA
(Updated [September 21, 2007]). Mucopolysaccharidosis Type I. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1993–2007. Available at http://www.genetests.org.
|
|
|
Clarke LA
(2008)
Idursulfase for the treatment of mucopolysaccharidosis II.
Expert Opinion on Pharmacotherapy
9:
311–317.
|
|
|
Coppa GV,
Catassi C,
Gabrielli O et al.
(1987)
Clinical application of a new simple method for the identification of mucopolysaccharidoses.
Helvetica Paediatrica Acta
42:
419–423.
|
|
|
Fan X,
Zhang H,
Zhang S et al.
(2006)
Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C).
American Journal of Human Genetics
79:
738–744.
|
|
|
Froissart R,
Da Silva IM and
Maire I
(2007)
Mucopolysaccharidosis type II: an update on mutation spectrum.
Acta Paediatrica
96(suppl.):
71–77.
|
|
|
Gabrielli O,
Clarke LA,
Bruni S and
Coppa GV
(2010)
Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up.
Pediatrics
125:
e183–e187.
|
|
|
Harmatz P,
Yu ZF,
Giugliani R et al.
(2010)
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.
Journal of Inherited Metabolic Disease
33:
51–60.
|
|
|
Hrebicek M,
Mrazova L,
Seyrantepe V et al.
(2006)
Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome).
American Journal of Human Genetics
79:
807–819.
|
|
|
Humbel R and
Chamoles NA
(1972)
Sequential thin layer chromatography of urinary acidic glycosaminglycans.
Clinica Chimica Acta; International Journal of Clinical Chemistry
40:
290–293.
|
|
|
Hunter C
(1917)
A rare disease in two brothers.
Proceedings of the Royal Society of Medicine
10:
104–116.
|
|
|
Hurler G
(1919)
Über einen Typ multipler Abartungen, vorwiegend am Skelettsystem.
Zeitschrift für Kinderheilkunde
24:
220–234.
|
|
|
Lerman MI and
Minna JD
(2000)
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Cancer Research
60:
6116–6133.
|
|
|
Li HH,
Zhao HZ,
Neufeld E,
Cai Y and
Gomez-Pinilla F
(2002)
Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B.
Journal of Neuroscience Research
69:
30–38.
|
|
|
Lualdi S,
Pittis MG,
Regis S et al.
(2006)
Multiple cryptic splice sites can be activated by IDS point mutations generating misspliced transcripts.
Journal of Molecular Medicine
84:
692–700.
|
|
|
Lualdi S,
Tappino B,
Di Duca M et al.
(2010)
Enigmatic in vivo iduronate-2-sulfatase (IDS) mutant transcript correction to wild-type in Hunter syndrome.
Human Mutation
31:
E1261–E1285.
|
|
|
Maroteaux P,
Lamy M and
Foucher M
(1963)
Morquio's disease. Clinical, radiological and biological study.
La Presse Médicale
71:
2091–2094.
|
|
|
ePath
Martin RA (Updated [November 7, 2007]). Mucopolysaccharidosis Type II. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1993–2007. Available at http://www.genetests.org.
|
|
|
McGill JJ,
Inwood AC,
Coman DJ et al.
(2010)
Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age–a sibling control study.
Clinical Genetics
77:
492–498.
|
|
|
book
McKusick VA
(1972)
Hereditable Disorders of Connective Tissue, 4th edn.
St. Louis: Mosby.
|
|
|
Miller RD,
Hoffmann JW,
Powell PP et al.
(1990)
Cloning and characterization of the human beta-glucuronidase gene.
Genomics
7:
280–283.
|
|
|
Modaressi S,
Rupp K,
von Figura K and
Peters C
(1993)
Structure of the human arylsulfatase B gene.
Biological Chemistry Hoppe-Seyler
374:
327–335.
|
|
|
Mok A,
Cao H and
Hegele RA
(2003)
Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase.
Genomics
81:
1–5.
|
|
|
Morris CP,
Guo XH,
Apostolou S et al.
(1994)
Morquio A syndrome: cloning, sequence, and structure of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene.
Genomics
22:
652–654.
|
|
|
Muenzer J,
Wraith JE and
Clarke LA
(2009)
International consensus panel on management and treatment of mucopolysaccharidosis I: management and treatment guidelines.
Pediatrics
123:
19–29.
|
|
|
Natowicz MR,
Short MP,
Wang Y et al.
(1996)
Clinical and biochemical manifestations of hyaluronidase deficiency.
New England Journal of Medicine
335:
1029–1033.
|
|
|
Nelson J
(1997)
Incidence of the mucopolysaccharidoses in Northern Ireland.
Human Genetics
101:
355–358.
|
|
|
book
Neufeld EF and
Muenzer J
(2001)
"The mucopolysaccharidoses". In:
Scriver CR,
Beaud AL,
Sly WE and
Valle D et al. (eds)
The Metabolic and Molecular Bases of Inherited Disease, 8th edn, pp.
3421–3452.
New York: McGraw-Hill.
|
|
|
Ohmi K,
Greenberg DS,
Rajavel KS et al.
(2003)
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.
Proceedings of the National Academy of Sciences of the USA
100:
1902–1907.
|
|
|
Oshima A,
Yoshida K,
Shimmoto M et al.
(1991)
Human beta-galactosidase gene mutations in Morquio B disease.
American Journal of Human Genetics
49:
1091–1093.
|
|
|
Piotrowska E,
Jakobkiewicz-Banecka J,
Tylki-Szymanska A et al.
(2008)
Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients.
Current Therapy Research
69:
166–1798.
|
|
|
Poorthuis BJ,
Wevers RA,
Kleijer WJ et al.
(1999)
The frequency of lysosomal storage diseases in the Netherlands.
Human Genetics
105:
151–156.
|
|
|
Rathmann M,
Bunge S,
Steglich C et al.
(1995)
Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28.
Human Genetics
95:
34–38.
|
|
|
Robertson DA,
Callen DF,
Baker EG et al.
(1988)
Chromosomal localization of the gene for human glucosamine-6-sulphatase to 12q14.
Human Genetics
79:
175–178.
|
|
|
Sanfilippo SJ,
Podosin R,
Langer LO Jr and
Good RA
(1963)
Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type).
The Journal of Pediatrics
63:
837–838.
|
|
|
Schaap T and
Bach G
(1980)
Incidence of mucopolysaccharidoses in Israel: is Hunter disease a “Jewish disease”?
Human Genetics
56:
221–223.
|
|
|
Scheie HG,
Hambrick GW Jr and
Barness LA
(1962)
A newly recognized forme fruste of Hurler's disease (gargoylism).
American Journal of Ophthalmology
53:
753–769.
|
|
|
Scott HS,
Anson DS,
Orsborn AM et al.
(1991)
Human alpha-l-iduronidase: cDNA isolation and expression.
Proceedings of the National Academy of Sciences of the USA
88:
9695–9699.
|
|
|
Scott HS,
Ashton LJ,
Eyre HJ et al.
(1990)
Chromosomal localization of the human alpha-l-iduronidase gene (IDUA) to 4p16.3.
American Journal of Human Genetics
47:
802–807.
|
|
|
Scott HS,
Blanch L,
Guo XH et al.
(1995)
Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.
Nature Genetics
11:
465–467.
|
|
|
Settembre C,
Fraldi A,
Jahreiss L et al.
(2008)
A block of autophagy in lysosomal storage disorders.
Human Molecular Genetics
17:
119–129.
|
|
|
Simonaro CM,
D'Angelo M,
He X et al.
(2008)
Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.
American Journal of Pathology
172:
112–122.
|
|
|
Stenson PD,
Mort M,
Ball EV et al.
(2009)
Human Gene Mutation Database (HGMD): 2008 update.
Genome Medicine
1:
13.
|
|
|
Tomatsu S,
Fukuda S,
Cooper A et al.
(1995)
Mucopolysaccharidosis IVA: Identification of a common missense mutation I113F in the N-acetylgalactosamine-6-sulfate sulfatase gene.
American Journal of Human Genetics
57:
556–563.
|
|
|
Tomatsu S,
Fukuda S,
Masue M et al.
(1991)
Morquio disease: isolation, characterization and expression of full length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase.
Biochemical and Biophysical Research Communications
181:
677–683.
|
|
|
Tomatsu S,
Okamura K,
Taketani T et al.
(2004)
Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
Pediatric Research
55:
592–597.
|
|
|
Valayannopoulos V,
Nicely H,
Harmatz P and
Turbeville S
(2010)
Mucopolysaccharidosis VI.
Orphanet Journal of Rare Diseases
5:
5–20.
|
|
|
Valstar MJ,
Ruijter GJ,
van Diggelen OP et al.
(2008)
Sanfilippo syndrome: a mini-review.
Journal of Inherited Metabolic Disease
31:
240–252.
|
|
|
Van Hoof F and
Hers HG
(1964)
L'ultrastructure les cellules hepatiques dans la maladie de Hurler (Gargoylisme).
Comptes rendus hebdomadaires des séances de l'Académie des sciences
259:
1281–1283.
|
|
|
Vervoort R,
Islam MR,
Sly W et al.
(1995)
A pseudodeficiency allele (D152N) of the human beta-glucuronidase gene.
American Journal of Human Genetics
57:
798–804.
|
|
|
Weber B,
Blanch L,
Clements PR et al.
(1996)
Cloning and expression of the gene involved in Sanfilippo B syndrome (mucopolysaccharidosis III B).
Human Molecular Genetics
5:
771–777.
|
|
|
Wilson PJ,
Morris CP,
Anson DS et al.
(1990)
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
Proceedings of the National Academy of Sciences of the USA
87:
8531–8535.
|
|
|
Wood TC and
Thompson JN
(2000)
Analysis of the heparin sulfamidase gene: mutation analysis in patients with Sanfilippo syndrome type A (MPS IIIA) and analysis of sulfamidase expression in normal adult brain.
American Journal of Human Genetics
67(suppl.):
A1635.
|
|
|
Wraith JE,
Scarpa M,
Beck M et al.
(2008)
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
European Journal of Pediatrics
167:
267–277.
|
|
|
Wynn RF,
Mercer J,
Page J et al.
(2009)
Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients.
Journal of Pediatrics
154:
135–139.
|
|
|
Yamada N,
Fukuda S,
Tomatsu S et al.
(1998)
Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: Nine novel mutations including T312S, a common allele that confers a mild phenotype.
Human Mutation
11:
202–208.
|
|
|
Yogalingam G and
Hopwood JJ
(2001)
Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications.
Human Mutation
18:
264–281.
|
|
|
Zhao HG,
Li HH,
Bach G,
Schmidtchen A and
Neufeld EF
(1996)
The molecular basis of Sanfilippo syndrome type B.
Proceedings of the National Academy of Sciences of the USA
93:
6101–6105.
|
| Further Reading |
|
|
Ballabio A and
Gieselmann V
(2009)
Lysosomal disorders: from storage to cellular damage.
Biochimica et Biophysica Acta
1793:
684–696.
|
|
|
Beck M
(2010)
Emerging drugs for lysosomal storage diseases.
Expert Opinion on Emerging Drugs
15:
495–507.
|
|
|
ePath
Brooks DA and
Fuller M
(2008)
Lysosomal disorders. Wiley Encyclopedia of Chemical Biology. Available at http://onlinelibrary.wiley.com/doi/10.1002/9780470048672.wecb297/abstract.
|
|
|
other
Cabrera-Salazar MA and
Barranger JA
(2006)
Lysosomal storage disorders: gene therapy.
eLS. DOI: 10.1038/npg.els.0005754.
|
|
|
Futerman AH and
van Meer G
(2004)
The cell biology of lysosomal storage disorders.
Nature Reviews. Molecular Cell Biology
5:
554–565.
|
|
|
Marsden D and
Levy H
(2010)
Newborn screening of lysosomal storage disorders.
Clinical Chemistry
56:
1071–1079.
|
|
|
other
Tutton R
(2010)
Biobanking: social, political and ethical aspects. In: Encyclopedia of Life Sciences (ELS). DOI: 10.1002/9780470015902.a0022083.
|
|
|
Walkley SU
(2007)
Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome.
Acta Paediatrica
96(suppl.):
26–32.
|
|
|
Walkley SU
(1998)
Cellular pathology of lysosomal storage disorders.
Brain Pathology
8:
175–193.
|
